No, it the completion of the 3/26 announced offering...
Somaxon Pharmaceuticals (SOMX) Sees Net Proceeds of $52.8 Million From Common Stock Offering
9:36 am ET 03/31/2010- StreetInsider
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced the closing of its previously announced public offering of 6,900,000 shares of its common stock, including 900,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters, at a price to the public of $8.25 per share. The net proceeds from the sale of the shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $52.8 million
